Renaissance Technologies’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.38M | Buy |
|
|||||
|
2025
Q1 | $5.48M | Sell |
|
|||||
|
2024
Q4 | $11.4M | Buy |
|
|||||
|
2024
Q3 | $8.92M | Sell |
|
|||||
|
2024
Q2 | $11.9M | Sell |
|
|||||
|
2024
Q1 | $21M | Buy |
|
|||||
|
2023
Q4 | $539K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.23M | Sell |
|
|||||
|
2022
Q2 | $9.07M | Buy |
|
|||||
|
2022
Q1 | $2.55M | Sell |
|
|||||
|
2021
Q4 | $3.65M | Sell |
|
|||||
|
2021
Q3 | $28.6M | Buy |
|
|||||
|
2021
Q2 | $3.35M | Sell |
|
|||||
|
2021
Q1 | $15.1M | Sell |
|
|||||
|
2020
Q4 | $30.3M | Sell |
|
|||||
|
2020
Q3 | $50.3M | Sell |
|
|||||
|
2020
Q2 | $82.6M | Buy |
|
|||||
|
2020
Q1 | $31.8M | Sell |
|
|||||
|
2019
Q4 | $40.8M | Sell |
|
|||||
|
2019
Q3 | $76.3M | Buy |
|
|||||
|
2019
Q2 | $57.9M | Buy |
|
|||||
|
2019
Q1 | $49.2M | Sell |
|
|||||
|
2018
Q4 | $53.6M | Buy |
|
|||||
|
2018
Q3 | $16.9M | Buy |
|
|||||
|
2018
Q2 | $4.54M | Buy |
|
|||||
|
2018
Q1 | $780K | Buy |
|
|||||
|
2017
Q4 | $63K | Buy |
|
|||||
|
2017
Q3 | $179K | Buy |
|
|||||
|
2017
Q2 | $142K | Buy |
|
|||||
|
2017
Q1 | $200K | Sell |
|
|||||
|
2016
Q4 | $654K | Sell |
|
|||||
|
2016
Q3 | $2.73M | Buy |
|
|||||
|
2016
Q2 | $2.22M | Buy |
|
|||||
|
2016
Q1 | $2.08M | Buy |
|
|||||
|
2015
Q4 | $1.94M | Buy |
|
|||||
|
2015
Q3 | $1.22M | Sell |
|
|||||
|
2015
Q2 | $2.43M | Buy |
|
|||||
|
2015
Q1 | $1.12M | Buy |
|